. Author manuscript; available in PMC: 2010 Apr 1.

Published in final edited form as: Nanomedicine (Lond). 2009 Jun;4(4):421–429. doi: 10.2217/nnm.09.24

Table 1.

Antimicrobial activity of silver nanocomposites.

Sample tested	MIC against Staphylococcus aureus (μM of sugar)	MIC against Escherichia coli (μM of sugar)
Ag–HA	0.025 ± 0.005	0.1 ± 0.01
Ag–DAPHP	0.1 ± 0.01	>0.1^*
Ag–glucose	>0.1^‡	>0.1^‡
HA	>1.0	>1.0
DAPHP	>1.0	>1.0

Data represent mean ± standard error of mean, n = 3.

Percent inhibition ranged from 20 to 30%.

^‡

Percent inhibition ranged from 0 to 10%.

Ag: Silver; DAPHP: Diaminopyridinylated heparin; HA: Hyaluronan; MIC: Minimum inhibitory concentration.